Vamifeport Clinical Trials (2026): 4 Studies for Healthy Volunteers & Healthy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
4 Vamifeport clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Healthy Volunteers & Healthy) and 162 total planned enrollment. 1 Vamifeport clinical trial is actively recruiting at 6 U.S. sites across 6 states. Most recent activity: NCT07332091 (Apr 2028).
Where to Participate: All Vamifeport Trial Sites in the U.S. (6 sites across 6 states)
Every actively recruiting Vamifeporttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Green Leaf Clinical Trials | Jacksonville32258 | NCT07332091 | Map |
| IN | Indiana University Health University Hospital | Indianapolis46202-5149 | NCT07332091 | Map |
| MD | American Oncology Partners, PA dba The Center for Cancer and Blood Disorders | Bethesda20817 | NCT07332091 | Map |
| MN | Aspirus St. Luke's Clinic - Duluth - Oncology & Hematology | Duluth55805 | NCT07332091 | Map |
| OK | Hightower Clinical - Oklahoma Cancer Center | Oklahoma City73174 | NCT07332091 | Map |
| WA | Washington State Univ Elson S. Floyd College of Medicine | Spokane99202-2131 | NCT07332091 | Map |
Vamifeport clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | Total |
|---|---|---|---|
| P1 | 3 | 3 | |
| P2 | 1 | 1 |
Recruiting Vamifeport clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07332091 | HFEEfficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis | P2 | Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis | 84 | Jan 2026 |
Vamifeport clinical trials by indication
Healthy Volunteers (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06996184 | — | P1 | completed | Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults |
| NCT06726863 | — | P1 | completed | Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults |
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07332091 | HFE | P2 | recruiting | Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis |
Healthy (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05077436 | — | P1 | completed | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects |
Vamifeport pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| HFE | NCT07332091 | P2 | recruiting | Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis | 84 | — |
All Vamifeport trials (4)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07332091 | HFE | Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis | P2 | recruiting | 84 | CSL Behring | Jan 2026 |
| NCT06996184 | Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults | P1 | completed | 28 | CSL Behring | May 2025 | |
| NCT06726863 | Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults | P1 | completed | 22 | CSL Behring | Nov 2024 | |
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | P1 | completed | 28 | Vifor (International) Inc. | Oct 2021 |
Vamifeport clinical trials: frequently asked questions
- How many Vamifeport clinical trials are there?
- 4 Vamifeport clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 3 are marked completed.
- Are Vamifeport clinical trials recruiting in 2026?
- Yes — 1 Vamifeport trial is actively recruiting in 2026, with 6 U.S. sites across 6 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Vamifeport being studied for?
- Vamifeport is being studied for Healthy Volunteers, Healthy, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis. The trials are grouped by indication on this page.
- What phase is Vamifeport in?
- Vamifeport clinical trials span 1 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Vamifeport clinical trials?
- The lead sponsor across the most Vamifeport trials is CSL Behring, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Vamifeportas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: